Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04955626 |
|---|---|
| Brief Title: | To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. |
| First Submitted : | June 9, 2021 |
| First Submitted that Met QC Criteria : | June 29, 2021 |
| First Posted : | July 9, 2021 |
| Last Update Submitted that Met QC Criteria : | February 23, 2023 |
| Last Update Posted : | February 24, 2023 |